Table 1 T-cell post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation

From: T-cell post-transplant lymphoproliferative disorder in a patient with chronic idiopathic myelofibrosis following allogeneic PBSC transplantation

Authors

Age/sex

Initial Dx

HSCT

Type of PTLD Dx (months after HSCT)

Origin

EBV

GVHD

Outcome (months after Dx)

Zutter et al.3

14/M

AML

HLA-identical BM graft

T-lymphoblastic lymphoma (43)

Recipient

Neg

Mild aGVHD(S,L,Gut)

Severe cGVHD(S,L,Gut)

Death (28)

 

9/M

ALL

HLA-identical BM graft

T-lymphoblastic lymphoma (21)

Donor

Neg

Mild aGVHD(S)

Severe cGVHD(S,L)

Death (6)

 

2/F

ALL

HLA-2 mismatched BM graft

Polymorphic T-cell lymphoma (2)

Donor?

Neg

Severe aGVHD(S,L)

Death (0)

Present case

44/F

CIMF

HLA-identical allogeneic PBSC

PTCL-u (5)

Recipient

Neg

aGVHDII(S3,L0,Gut0)

Extensive cGVHD(S,L)

Death (2)

  1. Abbreviations: aGVHD=acute GVHD; cGVHD=chronic GVHD; CIMF=chronic idiopathic myelofibrosis; Dx=diagnosis; F=female; Gut=gastrointestinal tract; HSCT=hematopoietic stem cell transplantation; L=liver; M=male; neg=negative; PTCL-u=peripheral T-cell lymphoma-unspecified; PTLD=post-transplant lymphoproliferative disorder; S=skin.
Back to article page